Stunner: Marc Garnick, one of the principal investigators into the drug Lupron when it was tested and approved by the FDA, responded to the New York Times’ story on the potential dangers of the medical treatment of gender dysphoria. I wrote about the story in a VIP column a couple of weeks ago.Read More
Gender drugs dangerous: Doc who helped get them approved
